fda glp-1 compounding warning september 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our BREAKING NEWS in the compounding

By inhibiting melanin production and protecting the skin from environmental damage, these products contribute to long-term skin clarity and brightness

161 Over a period of 24 weeks, all dosage groups of retatrutide showed significant improvements in reducing glycated hemoglobin (HbA1c) and body weight compared to the placebo group, especially in the higher dosage groups

These could cause hives, intense swelling, or even difficulty breathing

In parallel, there has been growing interest in probiotics as natural, safe, and accessible dietary supplements with the potential to support performance and recovery

Isolation and identification of bengle (Zingiber cassumunar roxb) as a stimulant in phagocytic activity of macrophages

Dwairy, M.D., is a Houston-born gastroenterologist at Houston Regional Gastroenterology Institute, treating patients in Sugar Land and Humble with expertise shaped by extensive training at UT Houston